GAITHERSBURG, Md. and SOUTH SAN FRANCISCO, Calif., March 24, 2020 /PRNewswire/ -- MaxCyte, Inc., a global cell-based therapies and life sciences company, and Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, t

NEW YORK, March 24, 2020 /PRNewswire/ -- The Coalition of Asian-American Independent Practice Association (CAIPA), which represents more than 1,000 physician and applied healthcare professionals in the five boroughs, today called for federal, state and local law enforcement organizations to crack down on the rising tide of hate crimes against Asian-American New Yorkers a

MONTREAL, March 24, 2020 /PRNewswire/ - Dollarama Inc. (TSX: DOL) ("Dollarama"), Canada's leading value retailer with nearly 1,300 stores from coast to coast, has been recognized as an essential business in Ontario and Quebec following the announcement of temporary exc

SAN DIEGO, California and CALGARY, Alberta, March 24, 2020 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced a favourable assessment from the Safety Committee following review of data from the window of

SAN DIEGO, March 24, 2020 /PRNewswire/ -- Today, Mesa Biotech announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its Accula™ SARS-CoV-2 Test, which gives COVID-19 diagnostic results in 30 minutes. Mesa Biotech Inc., a privately-held, molecular diagnostic company has developed an affordable, easy t

ENGLEWOOD, Colo., March 24, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE; the "Company"), a pre-revenue development stage biopharmaceutical company announced today that it has suspended patient enrollment in its Phase 3 clinical trial of Ampion ("AP-013") for the treatment of severe osteoarthritis of the knee ("OAK").

SAN DIEGO, March 24, 2020 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers, today announced that the Decipher® Prostate RP genomic test is now recommended in the 2020 National Comprehensive Cancer Network® (NCCN) Clinical P

SAN CARLOS, Calif., March 24, 2020 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced the completion of a $65 million equity financing. The financing was led by Decheng Capital and new investor Oceanpine Capit

CHICAGO, March 24, 2020 /PRNewswire/ -- Nature's Fynd, a food tech company producing a protein from a microbe originally discovered in the geothermal springs of Yellowstone's ancient volcano, has raised $80 million in new funding.The company was previously named Sustainable Bioproducts.Productio

ENGLEWOOD, Colo., March 24, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a pre-revenue development stage biopharmaceutical company focused on the development of immunology based therapies to treat prevalent inflammatory conditions for which limited treatment options exist, announced today that it is preparing an expanded access FDA pr